Colorectal Cancer Clinical Trials in Houston

Showing 61-80 of 166 trials

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

NCT04616196

This is a Phase 1b/2, open-label multicenter study evaluating NKTR-255 as a monotherapy and together with cetuximab in patients with head and neck squamous cell carcinoma (HNSCC) and colorectal carcinoma (CRC).

Head and Neck Squamous Cell CarcinomaColorectal Cancer

Nektar Therapeutics25 participantsStarted Oct 2020

San Diego, California, United States • San Francisco, California, United States • Minneapolis, Minnesota, United States +3 more locations

ACTIVE_NOT_RECRUITINGPHASE1/PHASE2< 1 mile

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single agent and in combination with pembrolizumab in participants with advanced or metastatic solid tumors and non-small cell lung cancers.

Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more

OncoC4, Inc.733 participantsStarted Sep 2020

Springdale, Arkansas, United States • Davis, California, United States • Downey, California, United States +34 more locations

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Colorectal Cancer Trials in Other Cities

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

Other Conditions in Houston